(Q42521263)

English

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells (English)

1 reference

Europe PubMed Central

1 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

1 November 2017

author name string

Shuang En Chuang

1

1 reference

Europe PubMed Central

1 November 2017

Pei Yen Yeh

2

1 reference

Europe PubMed Central

1 November 2017

Yen Shen Lu

3

1 reference

Europe PubMed Central

1 November 2017

Gi Ming Lai

4

1 reference

Europe PubMed Central

1 November 2017

Chao Ming Liao

5

1 reference

Europe PubMed Central

1 November 2017

Ming Gao

6

1 reference

Europe PubMed Central

1 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

1 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

1 November 2017

63

1 reference

Europe PubMed Central

1 November 2017

9

1 reference

Europe PubMed Central

1 November 2017

1709-1716

1 reference

Europe PubMed Central

1 November 2017

Control of apoptosis by Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

The Rel/NF-kappa B family: friend and foe.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

NF-kappaB to the rescue: RELs, apoptosis and cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Aberrant rel/nfkb genes and activity in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

The ATM protein is required for sustained activation of NF-kappaB following DNA damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2900931-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(02)00931-0

1 reference

Europe PubMed Central

1 November 2017

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42521263&oldid=1962111695"